Clare Lambert

Dr. Clare Lambert

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2018 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
CLClare Lambert
Clare Lambert
SSSusana Da Silva
Susana Da Silva
ACAmanda K. Ceniti
Amanda K. Ceniti
SRSakina J. Rizvi
Sakina J. Rizvi
GFGeorge Foussias
George Foussias
SKSidney H. Kennedy
Sidney H. Kennedy

17 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CLClare Lambert
Clare Lambert
OOOluwaseyi Olulana
Oluwaseyi Olulana
LBLisa Bailey-Davis
Lisa Bailey-Davis
Vida AbediVida Abedi
Vida Abedi
Ramin ZandRamin Zand
Ramin Zand
Recurrent ischemic strokes are a cause of significant healthcare burdens globally. Patients with uncontrolled vascular risk factors are more likely to develop recurrent ischemic strokes. This study aims to compile information gained from current secondary prevention programs. A pre-defined literature search strategy was applied to PubMed, SCOPUS, CINAHL, and Google Scholar databases, and studies from 1997 to 2020 were evaluated for quality, study aims, and outcomes. The search produced 1175 articles (1092 after duplicates were removed) and titles were screened; 55 titles were retained for the full-text analysis. Of the remaining studies, 31 were retained for assessment, five demonstrated long-term effectiveness, eight demonstrated short-term effectiveness, and 18 demonstrated no effectiveness. The successful studies utilized a variety of different techniques in the categories of physical fitness, education, and adherence to care plans to reduce the risk of recurrent strokes. The lessons we learned from the current prevention programs included (1) offer tailored care for underserved groups, (2) control blood pressure, (3) provide opportunities for medication dosage titration, (4) establish the care plan prior to discharge, (5) invest in supervised exercise programs, (6) remove barriers to accessing care in low resource settings, and (7) improve the transition of care.

30 March 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Vida AbediVida Abedi
Vida Abedi
CLClare Lambert
Clare Lambert
DCDurgesh Chaudhary
Durgesh Chaudhary
EREmily Rieder
Emily Rieder
VAVenkatesh Avula
Venkatesh Avula
Ramin ZandRamin Zand
Ramin Zand
Introduction: The cut-point for defining the age of young ischemic stroke (IS) is clinically and epidemiologically important, yet it is arbitrary and differs across studies. In this study, we leveraged electronic health records (EHRs) and data science techniques to estimate an optimal cut-point for defining the age of young IS. Methods: Patient-level EHRs were extracted from 13 hospitals in Pennsylvania, and used in two parallel approaches. The first approach included ICD9/10, from IS patients to group comorbidities, and computed similarity scores between every patient pair. We determined the optimal age of young IS by analyzing the trend of patient similarity with respect to their clinical profile for different ages of index IS. The second approach used the IS cohort and control (without IS), and built three sets of machine-learning models—generalized linear regression (GLM), random forest (RF), and XGBoost (XGB)—to classify patients for seventeen age groups. After extracting feature importance from the models, we determined the optimal age of young IS by analyzing the pattern of comorbidity with respect to the age of index IS. Both approaches were completed separately for male and female patients. Results: The stroke cohort contained 7555 ISs, and the control included 31,067 patients. In the first approach, the optimal age of young stroke was 53.7 and 51.0 years in female and male patients, respectively. In the second approach, we created 102 models, based on three algorithms, 17 age brackets, and two sexes. The optimal age was 53 (GLM), 52 (RF), and 54 (XGB) for female, and 52 (GLM and RF) and 53 (RF) for male patients. Different age and sex groups exhibited different comorbidity patterns. Discussion: Using a data-driven approach, we determined the age of young stroke to be 54 years for women and 52 years for men in our mainly rural population, in central Pennsylvania. Future validation studies should include more diverse populations.

24 December 2024 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Open access
CLClare Lambert
Clare Lambert
THTaimoor Hussain
Taimoor Hussain
JPJohn Peters
John Peters
ELErin E Longbrake
Erin E Longbrake
Introduction: Numerous immunomodulatory treatments exist for multiple sclerosis (MS), including those that deplete immune cells (e.g. anti-CD20 medications), relocate immune cells (e.g. natalizumab, S1P modulators), or modulate immune subsets (e.g. fumarates). All disease-modifying treatments (DMTs) can increase infection risk which could worsen with prolonged use. Methods: This is a retrospective, single-center, observational cohort study. We analyzed medical records of adult people with MS who took natalizumab, S1P modulators, fumarates or anti-CD20 medications for over two years between January 2013 and April 2021 at Yale. We identified severe infections (requiring hospitalization) and mild infections (identified through outpatient antibiotic prescriptions or chart reference to "infection"). We used a zero-inflated negative binomial regression to assess the effects of DMT use, treatment duration, and patient characteristics on infection likelihood and frequency, while controlling for biologic sex, body mass index, ambulatory status, Charlson Comorbidity Index (CCI), diagnosis, disease modifying therapy and treatment duration. Results: 104 patients received natalizumab, 61 fumarates, 17 S1P modulators and 291 anti-CD20 medications, with significant baseline differences in age, diagnosis, duration of DMT use, and CCI. Mild infection rates did not differ across DMTs, but severe infections were more common in patients on fumarates. Patients with longer DMT duration or requiring a walking aid had higher mild infection rates, while those with progressive MS or on longterm fumarates had higher severe infection rates, even after controlling for other variables. Discussion: This study demonstrates how real-life practice patterns, patient factors and DMT choice can influence infection rates, differing from randomized trial patterns. Natalizumab appears safe over extended use, while fumarates were linked to more severe infections, potentially due to the clinical selection of patients with poorer baseline health. The duration of DMT use may predict mild infection rates.

1 September 2024 in Neurology Education
Verified
Journal Article
Open access
CLClare Lambert
Clare Lambert
RNReshma Narula
Reshma Narula
VCVanessa Cooper
Vanessa Cooper
JMJeremy J. Moeller
Jeremy J. Moeller

1 June 2026 in Neurology Education
Verified
Journal Article
Open access
CLClare Lambert
Clare Lambert
JDJeffrey Dewey
Jeffrey Dewey
Neurology residents are often tasked with incorporating impromptu medical student teaching into their clinical workflow, yet few resources exist that combine content and pedagogical guidance in an efficient format. Residents are also learning themselves and may experience anxiety around teaching, compounded by the additional cognitive load of identifying and addressing student learning needs. We developed a guided worksheet tool to make high-yield, effective clinical neurology teaching accessible to busy residents. We piloted 4 self-guided worksheets on core neurology topics and examined student learning and the resident teaching experience. We aimed to (1) demonstrate successful student knowledge acquisition, retention, and satisfaction and (2) demonstrate improved resident teacher (RT) comfort, efficacy, and/or efficiency in clinical teaching on inpatient services. Four worksheets were developed: ischemic stroke basics, reading magnetic resonance imaging of the brain, intracranial hemorrhage, and seizures. Residents were asked to guide students through filling out a partially blank version, using a completed ‘master’ version as a guide, while providing targeted teaching when knowledge gaps were apparent. Student learning was assessed using presession, postsession, and two-week postsession quizzes. Qualitative analysis was performed on semistructured interviews with RTs to understand their experience teaching with the tool. Six RTs taught 27 medical students a total of 47 lessons. Learner knowledge scores improved immediately after lessons (1.24/3 ± 0.92 before lesson vs 2.75/3 ± 0.49 after lesson, p < 0.001) and were sustained at 2 weeks after lesson (1.24/3 ± 0.92 before lesson vs 2.47 ± 0.61 2 weeks after lesson, p < 0.001). RTs believed that the tool improved their clinical teaching, with themes of reducing stress around impromptu teaching, improving basic content delivery, the power of microlearning, and developing self-efficacy identified in qualitative interviews. Guided worksheets offer content and can support RTs in providing effective clinical teaching while improving their comfort and self-efficacy. Expansion of these tools to additional high-yield topics may offer further support for resident teaching in the clinical setting.